hmmm seems like all we really have going for us now is PTX-100. Omnicar seems to be shelved because a trial is too expensive to run. Sounds like they want to wait until they can find a partner to fund it or until the Biotech sector improves perhaps.
If the FDA don't approve this PTX-100 registration study, this stock is going to sit on the low cents for the foreseeable future. Even if they do approve it, a P2 will take 2-3 years so i have no high hopes for the share price increasing any time soon.
Not a very good short-term outlook unfortunately IMO.
hmmm seems like all we really have going for us now is PTX-100....
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
-0.002(4.17%) |
Mkt cap ! $37.04M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.6¢ | $94.55K | 2.033M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7000 | 4.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 550000 | 2 |
View Market Depth
| Last trade - 15.36pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
4.8¢ |
Change
-0.002 ( 2.04 %) |
||||
| Open | High | Low | Volume | ||
| 4.7¢ | 4.8¢ | 4.5¢ | 409565 | ||
| Last updated 15.51pm 03/05/2024 ? | |||||
| PTX (ASX) Chart |